Gene · 8529
Papers1,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Simvastatin inhibits 20-Hydroxyeicosatetraenoic acid formation: docking and in vitro assay. | BMC Pharmacol Toxicol | 2025 | 40826111 | PubTator, text mining | PubMed |
| Mitochondrial fission genes MTFP1/MTFP2 as predictive biomarkers in prostate cancer: a mendelian randomization study. | Discov Oncol | 2025 | 40824549 | PubTator, text mining | PubMed |
| Oxidative stress in pediatric diseases associated with the origin of life and growth and development. | Front Cell Dev Biol | 2025 | 40735644 | PubTator, text mining | PubMed |
| Integrated analysis identifies key genes underlying the bidirectional association between depression and renal failure. | Sci Rep | 2025 | 40595897 | PubTator, text mining | PubMed |
| Unveiling the heritability of selected unexplored pharmacogenetic markers in the Saudi population. | Front Pharmacol | 2025 | 40376268 | PubTator, text mining | PubMed |
| Changes in Protein Expression of Renal Drug Transporters and Drug-Metabolizing Enzymes in Autosomal Dominant Polycystic Kidney Disease Patients. | Clin Pharmacol Ther | 2025 | 40371605 | PubTator, text mining | PubMed |
| The impact of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin dose requirement in Saudi patients. | Front Pharmacol | 2025 | 40371326 | PubTator, text mining | PubMed |
| Synergistic Effects of Low-Frequency Ultrasound and Therapeutic Agents on Endothelial and Renal Cells: Emphasis on Cell Functionality, Oxidative Stress, and Inflammatory Markers. | Pharmaceuticals (Basel) | 2025 | 40143180 | PubTator, text mining | PubMed |
| Pharmacodynamic Modeling of Warfarin Dosing Algorithm for Cardiovascular Patients in Indonesia: A Tailored Method to Anticoagulation Therapy. | Drug Des Devel Ther | 2025 | 39896937 | PubTator, text mining | PubMed |
| Evaluating Cetuximab Regimens in Head and Neck Cancer: Insights from a Retrospective Cohort Study. | Cancers (Basel) | 2025 | 39857992 | PubTator, text mining | PubMed |
| Protein abundance of drug transporters and drug-metabolizing enzymes in paired healthy and tumor tissue from colorectal cancer patients. | Int J Pharm | 2025 | 39809348 | PubTator, text mining | PubMed |
| [Precision Medicine for Patients with Renal Cell Carcinoma Based on Drug-metabolizing Enzyme Expression Levels]. | Yakugaku Zasshi | 2025 | 39756928 | PubTator, text mining | PubMed |
| Clinical Pharmacogenetic Testing and Application: 2024 Updated Guidelines by the Korean Society for Laboratory Medicine. | Ann Lab Med | 2025 | 39681357 | PubTator, text mining | PubMed |
| Genetic Variability of CYP4F2, CYP2D6, CYP2E1, and ACE in the Chinese Yi Population. | Biochem Genet | 2025 | 38850376 | PubTator, text mining | PubMed |
| The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease. | Front Physiol | 2024 | 39959811 | PubTator, text mining | PubMed |
| Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy. | Sci Rep | 2024 | 39738187 | PubTator, text mining | PubMed |
| Pharmacogenomic landscape of the Thai population from genome sequencing of 949 individuals. | Sci Rep | 2024 | 39730427 | PubTator, text mining | PubMed |
| Editorial: Cytochromes P450, their modulators and metabolites in cardiovascular function and disease. | Front Pharmacol | 2024 | 39697552 | PubTator, text mining | PubMed |
| Pharmacogenomic profiling of the South Korean population: Insights and implications for personalized medicine. | Front Pharmacol | 2024 | 39691389 | PubTator, text mining | PubMed |
| Identification of key genes and diagnostic model associated with circadian rhythms and Parkinson's disease by bioinformatics analysis. | Front Aging Neurosci | 2024 | 39478700 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8529/papers?page=3